Pez
Selected indexed studies
- PTP-Pez: a novel regulator of TGFbeta signaling. (Cell Cycle, 2008) [PMID:18677119]
- Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. (N Engl J Med, 2025) [PMID:40267423]
- Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD. (N Engl J Med, 2020) [PMID:32579807]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD. (2020) pubmed
- Benralizumab for the Prevention of COPD Exacerbations. (2019) pubmed
- PTP-Pez: a novel regulator of TGFbeta signaling. (2008) pubmed
- Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. (2025) pubmed
- PI4P-mediated solid-like Merlin condensates orchestrate Hippo pathway regulation. (2024) pubmed
- PTPN21/Pez Is a Novel and Evolutionarily Conserved Key Regulator of Inflammation In Vivo. (2021) pubmed
- Lipopolysaccharide transport and assembly at the outer membrane: the PEZ model. (2016) pubmed
- Endemic Kaposi's Sarcoma. (2023) pubmed
- Pez: a novel human cDNA encoding protein tyrosine phosphatase- and ezrin-like domains. (1995) pubmed
- pez: phylogenetics for the environmental sciences. (2015) pubmed